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ABSTRACT
Epigenetics, and more specifically DNA methylation
is a fast evolving research area. In almost every
cancer type, each month new publications confirm
the differentiated regulation of specific genes
due to methylation and mention the discovery of
novel methylation markers. Therefore, it would be
extremely useful to have an annotated, reviewed,
sorted and summarized overview of all available
data. PubMeth is a cancer methylation database
that includes genes that are reported to be methyl-
ated in various cancer types. A query can be based
either on genes (to check in which cancer types the
genes are reported as being methylated) or on
cancer types (which genes are reported to be
methylated in the cancer (sub) types of interest).
The database is freely accessible at http://
www.pubmeth.org.
PubMeth is based on text-mining of Medline/
PubMed abstracts, combined with manual reading
and annotation of preselected abstracts. The text-
mining approach results in increased speed and
selectivity (as for instance many different aliases
of a gene are searched at once), while the manual
screening significantly raises the specificity and
quality of the database. The summarized overview
of the results is very useful in case more genes
or cancer types are searched at the same time.
INTRODUCTION
DNA methylation represents a modiﬁcation of DNA
by addition of a methyl group to a cytosine, also referred
to as the ﬁfth base (1). This reaction uses S-adenosyl-
methionine as a methyl donor and is catalysed by a group
of enzymes, the DNA methyltransferases (DNMTs).
In humans and other mammals, this epigenetic modiﬁca-
tion is almost exclusively imposed on cytosines that
precede a guanosine in the primary DNA sequence
(often called a CpG dinucleotide). The frequency of
these CpGs in the genome is much lower than would be
expected as a methylated cytosine often is subject to
deamination thereby forming thymidine. However, in
some regions, dense clusters of CpGs can be identiﬁed:
these regions are referred to as CpG islands (2).
DNA methylation is an epigenetic change: it does
not alter the primary DNA sequence and might contribute
to overall genetic stability and maintenance of chromoso-
mal integrity. Consequently, it facilitates the organization
of the genome into active and inactive regions with respect
to gene transcription (3). Genes with CpG islands in their
promoter region are generally unmethylated in normal
tissues. Upon DNA hypermethylation, transcription of
the aﬀected genes may be blocked, resulting in gene
silencing. In neoplasia, abnormal patterns of DNA
methylation have been recognized. Hypermethylation is
now considered one of the important mechanisms result-
ing in silenced expression of tumor suppressor genes, i.e.
genes responsible for control of normal cell diﬀerentiation
and/or inhibition of cell growth. In the last few years,
new hypermethylated biomarkers have been used in
cancer research and diagnostics (4).
MethDB (5), one of the few databases that focus
on DNA methylation, is general and sample oriented.
But it is not optimized to cancer-related queries because
this type of query requires a summarized overview.
However, in MethDB querying multiple genes or cancer
types is not supported and data is always handled as
a separate sample. Another database, MethPrimerDB (6),
has a focus on detection methodologies (e.g. MSP primer
design). Both databases discussed here, depend on
submissions by administrators or users, which guarantees
the required quality of the databases, but consequently
they are not always complete and up to date. The
databases are neither designed to rank and summarize
cancer-related information [genes and cancer (sub)types
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research in the cancer ﬁeld.
Hereby we present PubMeth, a database that combines
a text-mining approach (fast, intelligent to search multiple
aliases and textual variants of these aliases, querying
multiple keyword lists at once) with a manual reviewing
and annotation step. The latter one drastically improves
speciﬁcity and annotation quality. The interface is able
to rank, summarize and represent data, making the
information the database contains easily accessible.
The reviewing step also heavily depends on the text-
mining step that sorts abstracts, highlights terms and
provides links to diﬀerent sources. This way, the reviewing
step can be done fast and accurate enough to process
all abstracts, electronically published until now in
PubMed. In addition, using this approach, an update
strategy can be more easily implemented.
DNA methylation in cancer research has evolved to
a mainstream research topic. Methylation proﬁles are
successfully used in early detection and personalized
treatment. However, more and more data is available,
especially with the availability of large-scale screening
techniques. All the information taken together determines
the knowledge of the ‘cancer methylome’. Ultimately, the
epigenome of all cancer tissues, including those of diﬀ-
erent stage and grade, could be mapped out. Epigenetic
states diﬀer widely among tissues, and changes are far
more varied and much more frequent per tumor than
DNA mutations. ‘Each diﬀerentiated cell has a diﬀerent
epigenome’, said Jones (7). In this perspective, it is very
useful to extract which genes are already reported in which
cancer types from literature. This information might
be used as positive controls, to check the same genes in
other (related) cancer types, to screen for markers that
could be used as early diagnostic utility or in the context
of personalized medicine and to deepen the knowledge
of the mechanisms of methylation.
PubMeth tries to contain and summarize as many
available literature data and presents them in a easy to use
graphical interface. It speeds up the process of searching
relevant literature, many aliases and keywords are
searched at the same time and the results are reliable as
they are manually reviewed as one would do when
performing a manual literature search.
FILLING UP THE DATABASE
Abstracts, related to epigenetics and methylation, are
downloaded in XML-format through NCBI E-Utils
(E-fetch) using more than 15 methylation-related key-
words (such as methylation, DNA methylation, methyl-
ated, epigenetic and a range of variants, as well as
detection technologies). The aliases, symbols and descrip-
tions of human genes, associated with an Ensembl ID, are
obtained using a Perl-script. This queries the GeneCards
database (8) that already combines diﬀerent genetic
databases such as Ensembl and Entrez Gene. Diﬀerent
textual variations of all aliases are generated to be as
complete as possible (e.g. variants for BRCA1 include
BRCA 1, BRCA-1, BRCAI, BRCA I and BRCA-I).
To avoid counting and highlighting aliases that are
also common English words, an alias is rejected if more
than 100000 PubMed abstracts are retrieved. A list
(http://www.wordcount.org) of frequently used English
words is searched at the same time.
Cancer-related keywords were obtained from a list
of the National Cancer Institute (http://www.cancer.gov/
cancertopics/alphalist) and keywords related with
detection methodologies were manually compiled.
One by one, abstracts are searched for aliases and
their variants, methylation-related keywords, sentences
with both an alias and such a keyword. In addition, terms
related with cancer and detection methodology are
also highlighted and counted. This information is stored
in a MySQL 5 relational database using Perl-DBI. Based
on the information in this database, abstracts are ranked.
This ranking is based on a large number of parameters
such as the number of aliases, the number of diﬀerent
genes, the number of diﬀerent aliases per gene, the number
of sentences with both an alias and a methylation-related
keyword, the presence of detection methodology
and cancer-related keywords.
Abstracts are then manually reviewed, taking into
accounttheorderafterranking,withtheaidofhighlighting
the diﬀerent keyword lists, aliases and sentences with alias
and methylation-related keyword in diﬀerent colors.
Aliases are linked with gene information using hover-over
eﬀects generated with JavaScript and CSS. After manual
reviewing, the information in the database only has to be
minimally updated or corrected. A schematic overview of
the complete process is given in Figure 1. This process is
still in progress; due to the ranking system the most
important publications are currently in the database. The
remaining abstracts will be reviewed soon, and an accurate
update strategy will be developed.
QUERYING THE DATABASE
A record in the database contains information about
the source of publication, the gene, the cancer type and
subtypes if speciﬁed. It includes the number of primary
cancer samples where methylation is analysed in, as well as
the number of analysed cell lines and the number of
normal tissues. For all these three categories the methyla-
tion frequency (the percentage of the samples that show
methylation) is also available. Other information includes
the detection technologies used and an ‘evidence sentence’
where most of the information in this record came from.
PubMeth can be queried using the web-interface at
http://www.pubmeth.org in two ways, depending on the
researcher’s focus:
(1) Gene-related: in which cancer types (and subtypes)
the genes of interest are reported to be methylated
(2) Cancer-related: which genes are reported to be
methylated in the cancer types/subtypes
Gene-centric query
A query is created in two easy steps. In the ﬁrst step, the
user provides a list of genes (diﬀerent identiﬁers are
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The query is analysed using local symbol/alias lists,
generated using GeneCards, and suggestions are presented
to the user. In the second step, the user reviews the
selections made (most likely the genes selected due to
intelligent sorting in the background are correct) and
submits his choices.
At this point, the results will be generated and the main
result page is presented to the user. This main result page
ranks the genes, based on the number of references to the
gene in the database. A graphical summary representation
of the number of references, the number of primary
samples and the mean methylation frequency within
diﬀerent cancer types is also given (example in Figure 2).
The summary is very useful if multiple genes are
searched at once; this feature is what distinguishes this
database from previous eﬀorts. One practical usage
example would be that, using a pharmacologic demethyla-
tion approach in cell lines, 50 candidate genes are selected.
The question then is to subselect genes to verify in primary
cancer samples, often based on time-consuming literature
searches. This selection is facilitated by the summarization
view of PubMeth.
From this main page, one can go to the detailed pages,
focusing on a selected gene in a certain cancer type. On
such a detailed page, graphical representations of the
number of references in the database, the total number of
samples and the mean methylation frequency are dis-
played for the diﬀerent cancer types and their subtypes.
The complete individual records, linked with their original
PubMed record, are shown. Users can also choose to
browse a precomputed genelist. Advantage is that the user
can browse all genes in PubMeth without having to query
the database, which is signiﬁcantly faster. However, the
summary view is not available.
Cancer-centric query
A cancer-centric query is executed in one easy step:
the user selects cancer types (and/or subtypes up to
three levels—e.g. lymphoma, non-Hodgkin lymphoma,
b-cell lymphoma and diﬀuse large B-cell). An overview (in
the same style as the gene-centric searching approach) of
the genes that are most commonly described as methylated
in the selected cancer types, as well as the total number of
samples and the mean methylation frequency is returned.
From this summary page, navigating to detailed pages is
intuitive.
This type of search is meant to get a quick overview of
the genes that are reported in the methylation context in
the cancer (sub) types of interest and in which frequency,
to explore methylation in the cancer types of interest, to
compare experimental results with or to perform, in a next
Figure 1. Scheme that illustrates the initial ﬁlling up of database using text-mining. Aliases of genes and diﬀerent keyword lists (methylation, cancer
and detection-related) are highlighted in the abstract. At the same time, diﬀerent parameters are counted and stored in a MySQL relational database.
Afterwards, the data is ranked and manually reviewed.
D844 Nucleic Acids Research, 2008, Vol. 36, Databaseissuestep, a gene-centric search on these genes for full details in
all cancer (sub) types.
A screencast that dynamically shows how to query
PubMeth is available on the PubMeth website.
PERFORMANCE OF PUBMETH, DISCUSSION
AND FUTURE
To evaluate the performance of PubMeth, we tested how
well the database performed in comparison with a careful
manual literature search. Therefore, we selected a very
recent review, focusing on DNA methylation in breast
cancer (9). This article contains a table where the authors
provide a list of 39 genes, known to be hypermethylated
in breast cancer and their literature references. The genes
in this list are entered into the gene-centric search of
PubMeth: 27 genes are listed in PubMeth, 11 are not listed
and 1 gene could not be associated with a gene symbol.
Of the 27 genes listed in PubMeth, 20 are described in
breast cancer. Breast cancer is listed ﬁrst on the results
page due to the background sorting mechanisms, but 18
genes are not associated with breast cancer in PubMeth.
On the other hand, the review article lists 39 diﬀerent
genes, while a cancer-centric search for breast cancer
returns 94 genes. Important to mention: the genes both in
PubMeth and the review (the shared group) are associated
with a high number of primary samples in PubMeth. If all
94 genes were ranked according to the number of primary
samples in decreasing order, most members of the shared
group are on top of this ranking, almost the complete top
10 is present in the shared group (except numbers 7 and 8).
This example clearly shows the power of PubMeth as
well as its weaknesses. First of all, doing such a literature
search manually usually takes multiple hours, while
PubMeth presents its summary within minutes. PubMeth
is in most cases able to ﬁnd more references than a manual
search would, using the diﬀerent keywords and alias lists.
On the contrary, often abstracts do not mention any of the
genes in question, and these abstracts are not taken into
account for consideration in PubMeth. Examples of such
articles are large-scale studies with multiple genes or
reviews. The articles generally are easily found by manual
searches but not using our text-mining approach that is
only able to screen abstracts.
As long as there is no universal or centralized system
to be able to screen full text articles or a mainstream open
access strategy, solution for this would be to leave the
restriction that the abstract has to contain a gene out
and to do more general searches. Other possibility is
to allow users to enter their suggestions for inclusion
into PubMeth; such a submission system would allow to
combine the power of both submissions by users and an
automated text-mining approach that demonstrates to
be very powerful dealing with diﬀerent keyword lists
and gene name variants. The latter is available on the
PubMeth website: articles related with DNA methylation
Methylation frequency:  0 0-20 % 20-40 % 40-60 % 60-80 % 80-100 %
breast 478 593 148 570 630 - 527 374 257 - 
cervical 658 759 586 433 397 82 - - 89 - 
cardial 50 - -  -  50 -  -  -  -  - 
oesophaegeal 299 159 383 27 179 48 - 41 - - 
liver 1271 545 284 450 339 301 687 135 29 124
larynx - -  92 -  -  -  -  -  -  - 
salivary gland 96 60 96 - -  -  -  -  - 36
gall bladder 114 9 55 59 105 50 - - 50 - 
oral 362 36 103 197 34 121 - -  -  23
small bowel 56 - -  -  56 -  -  -  -  - 
ovarian 802 676 79 115 72 52 48 259 92 - 
brain 1086 460 1981 229 - 313 141 163 32 468
neuroblastoma 183 193 83 27 - -  27 - -  38
neuroendocrine - -  -  -  20 -  -  -  -  - 
mucoepidermoid carcinoma - -  -  46 -  -  -  -  -  - 
wilms tumour 79 102 71 - -  -  1 -  -  - 
lymphoma 452 132 292 - -  415 28 -  - 46
gastric 2162 379 1284 1724 635 170 756 - -  - 
NULL - 85 108 17 17 -  -  -  -  - 
bone 11 - 8 19 -  -  -  -  -  - 
endocrine 67 176 - 25 -  42 -  -  -  42
kidney 154 501 160 175 110 - 99 -  -  - 
pancreas 198 140 140 112 106 58 58 - 33 - 
colorectal 3935 925 3184 769 1173 393 374 - 159 - 
leukaemia 1114 52 40 606 - 1463 - 222 535 49
mesothelioma 17 6 6 6 6 - 6 6 -  - 
nasopharyngeal 71 98 - 165 -  71 -  -  - - 
skin 133 234 146 138 - -  -  107 -  20
bile duct 203 28 46 65 - -  -  27 -  - 
prostate 514 944 348 568 846 - 1691 214 280 48
Figure 2. Summary page of a gene-centric query. The diﬀerent colors represent the frequency of methylation of the gene in the diﬀerent cancer types
(what percentage of the samples showed methylation), while the numbers indicate the total number of primary samples tested for methylation.
Nucleic Acids Research, 2008,Vol. 36,Database issue D845in cancer that could not be found with PubMeth, can be
suggested for inclusion.
Currently, PubMeth only focuses on hypermethylation;
however, the inclusion of hypomethylated genes would be
useful as well for some users. In a next update, keywords
related with hypomethylation will be added.
Other future database updates should take into account
diﬀerent originating tissues (for example, clearly separate
between primary cancer tissue and serum) and the
diﬀerent types of normals (surrounding tissue in tumor
patient versus samples from healthy person). However,
diﬀerent articles use diﬀerent terminologies and often this
information is not easily extractable.
Improvements to the interface should represent the
above described separation of samples. Currently, only the
mean of the methylation frequency in primary cancers is
given. This could be extended to give an idea of the degree
of variation in the diﬀerent experiments and the diﬀerent
methods, the diﬀerence between cancer and normal tissue
and the frequency in cell lines. However, it is a real
challenge to present all this useful information in a clear
interface that is easy to overview and browse.
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